Chin Kok-Yong, Ng Ben Nett, Rostam Muhd Khairik Imran, Muhammad Fadzil Nur Farah Dhaniyah, Raman Vaishnavi, Mohamed Yunus Farzana, Syed Hashim Syed Alhafiz, Ekeuku Sophia Ogechi
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
J Clin Med. 2022 Oct 30;11(21):6434. doi: 10.3390/jcm11216434.
Osteoporosis refers to excessive bone loss as reflected by the deterioration of bone mass and microarchitecture, which compromises bone strength. It is a complex multifactorial endocrine disease. Its pathogenesis relies on the presence of several endogenous and exogenous risk factors, which skew the physiological bone remodelling to a more catabolic process that results in net bone loss. This review aims to provide an overview of osteoporosis from its biology, epidemiology and clinical aspects (detection and pharmacological management). The review will serve as an updated reference for readers to understand the basics of osteoporosis and take action to prevent and manage this disease.
骨质疏松症是指骨量和微结构恶化所反映的骨质过度流失,这会损害骨骼强度。它是一种复杂的多因素内分泌疾病。其发病机制依赖于多种内源性和外源性风险因素的存在,这些因素将生理性骨重塑偏向于一个更具分解代谢的过程,导致净骨量流失。本综述旨在从生物学、流行病学和临床方面(检测和药物治疗)对骨质疏松症进行概述。该综述将为读者提供最新参考,以了解骨质疏松症的基础知识并采取行动预防和管理这种疾病。